A little time ago I said that one of our papers was in a competition in a scientific journal for the best paper in there over a 4 year period since the journal started. With your help and support, we have won this competition, and out of 12 papers, ours received over one third of the votes. I take this opportunity to thank all those who supported us in voting. The outcome is that the paper will feature in the September Newsletter of the journal, and also I believe will give it much more publicity. To remind you the paper was about the variability in the human response to thyroxine therapy stemming from the variation originally found in the population in health. This leads inevitably to a minority of patients needing more than just T4 to achieve some sort of optimum treatment i.e. T3.